[SaneVax: During the last year, the FDA approved four new influenza vaccines. The Advisory Committee on Immunization Practices (ACIP) chose to postpone discussing new evidence indicating flu vaccine effectiveness may not last an entire flu season. They also postponed discussions on how medical professionals should choose which new flu vaccine to use. The only decision they […]
In latest vaccine marketing fraud, CDC says Gardasil shots should be ‘routine’ for boys
By: Jonathan Benson, staff writer (NaturalNews) Every male between the ages of 11 and 21 should get a Gardasil vaccine for cervical cancer, and those between the ages of 13 and 21 should also get “catch-up” shots later down the road. This is only the opinion of the U.S. Centers for Disease Control and Prevention’s […]
3 changes to children’s vaccine recommendations announced
By Cari Nierenberg, MyHealthNewsDaily, The nation’s largest pediatrician group today released its new schedule of recommended childhood vaccinations. It made three major changes to its previous recommendations, after a federal advisory panel of experts reviewed recent evidence from vaccine studies. The biggest change is the new recommendation that boys should be vaccinated against human papillomavirus (HPV). Since […]
New Criteria for Vaccinations
The New Criteria 3. Prior to December 14, 2009, the CDC required vaccinations against vaccine-preventable diseases explicitly listed in section 212(a)(1)(A)(ii) of the Immigration and Nationality Act (INA), as well as all vaccinations recommended by the ACIP for the general U.S. population. Under the new criteria effective December 14, the CDC continues to require vaccinations […]
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance From the Advisory Committee on Immunization Practices (ACIP)
MMWR. 2010;59:630-632 On October 16, 2009, the Food and Drug Administration licensed quadrivalent human papillomavirus vaccine (HPV4; Gardasil, Merck & Co. Inc.) for use in males aged 9 through 26 years for prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. HPV4 had been licensed previously for use in females aged […]
